Non-invasive Aesthetic Treatment Market Size, Share & Trends Analysis Report By Procedure (Skin Rejuvenation, Injectable), By End Use (Hospital/Surgery Center, MedSpa), By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global non-invasive aesthetic treatment market size was valued at USD 61.2 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 15.40% from 2023 to 2030. The growing focus on physical appearance among adults has led to an increased demand for non-invasive aesthetic treatments in recent years. Another key revenue-generating population to watch out for is the ones aged 50 years and above. Women, in particular, in this age group are opting for fillers and injectables including the popular Botox. According to the American Society for Aesthetic Plastic Surgery (ASAPS), in 2018, around 3.8 million minimally invasive cosmetic surgeries were carried out in the U.S. within the age group of 55 years and above. This highlights high growth prospects that lie ahead for the market in the country.

According to the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. was ranked first, in terms of non-surgical procedures performed at a global level. The country is backed by the availability of advanced treatment options and has the highest number of surgeons at a global level, with over 7,000 plastic surgeons, as per 2019 estimates. The growing consciousness about fitness and overall appearance has increased the demand for non-invasive aesthetic treatments in developing countries. In countries, such as India, these treatments are gaining consumer interest.

The country ranks among the top 5, in terms of surgical procedures performed. Thus, developing countries are expected to be key revenue pockets for the market in the years to come. The COVID-19 pandemic has significantly affected the overall market. The cosmetics industry relies on close physical contact with their clients, leaving it negatively affected. Practitioners have also raised concerns over the downturn in patient interest owing to a sharp cut in income. The market is expected to witness a phase of short-term negative growth. Companies are expected to address this by offering maximum support to their customers.

COVID19 impact: A 51.2% increase in demand was observed

For instance, leading player, Allergan, has assured support for its r BOTOX® operations and patient assistance. The company’s team is reachable through email communication and video conference. Recently, amidst the pandemic, remote working has increased the time spent on Zoom calls. Adults are paying attention to their physical appearance closely. This has increased the demand for cosmetic surgeries, with Botox being one of the most popular procedures preferred. Patients are also opting for cosmetic surgeries owing to ease of recovery while staying at home.

Procedure Insights

On the basis of procedures, the global market has been segmented into injectable, skin rejuvenation, and others. The injectable segment led the market in 2022 with a revenue share of more than 63%. The segment is estimated to retain the leading position growing at the fastest CAGR during the forecast period. Injectable can be easily used by surgeons and provide faster treatment with quick results and less downtime as compared to others.The others segment includes hair removal, non-surgical fat reduction, sclerotherapy, and cellulite treatments. Nonsurgical fat reduction is estimated to register the fastest CAGR during the forecast period.

Laser hair removal is also gaining popularity as it is cost-effective and saves time compared to waxing, shaving, or using hair removal creams. According to the International Society of Aesthetic Plastic Surgery (ISAPS), hair removal was among the top 5 nonsurgical procedures carried out at a global level in 2019. The skin rejuvenation procedure segment is expected to record the second-fastest CAGR from 2022 to 2030. This growth can be credited to the high demand for skin rejuvenation treatment on account of its efficiency in restoring the patient’s youthful appearance through skin alterations. This procedure can do more than avoid skin aging and stop premature aging.

End-use Insight

On the basis of end uses, the global market has been divided into hospital/surgery centers, MedSpa, traditional spa, and HCP-owned clinics. The medspa end-use segment accounted for the largest share of more than 34% of the global revenue in 2022. The segment is projected to expand further at the fastest CAGR maintaining its dominant position over the forecast period. Medspa is a facility where cosmetic services are provided under the supervision of a licensed physician. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals.

These facilities follow all the regulatory policies and standards set by the government and have to be mandatorily owned by a physician. MedSpas are increasingly adopting novel treatment systems to gain a higher market share. The employees in medspas need to have a license in esthetics as well as medical education. Factors, such as membership subscriptions, service marketing, adoption of novel laser technologies, and availability of cost-effective treatments, are expected to significantly boost the growth of this segment. The hospital/surgery center segment held the second-highest market share while the traditional spa segment is estimated to record the second-fastest CAGR from 2022 to 2030.

Regional Insights

On the basis of geographies, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the maximum share of more than 35.4% of the global revenue in 2022. The region will retain the leading position throughout the forecast period owing to the increasing demand for cosmetic procedures. The growth in demand for cosmetic surgery procedures from the year 2000 to 2018 was compared by the ASPS. It was observed that the use of Botox injections increased by 845%.

Thus, North America is expected to be a key revenue-generating region for the market in the coming years. Asia Pacific, on the other hand, is projected to register the fastest growth rate of more than 17.2% during the forecast period. The growth of the Asia Pacific regional market is backed by countries, such as China, India, and Thailand. The growing consciousness about physical appearance among the consumers in these developing countries is expected to play a key role in boosting the demand for non-invasive aesthetic procedures. Thailand, in particular, is projected to be the fastest-growing country during the forecast period.

Key Companies & Market Share Insights

The global market is highly competitive due to the presence of several global companies. Key players are focusing on growth strategies, such as enhancements in the existing technologies, geographical expansions, product launches, and product approvals, to gain higher market shares. For instance, in February 2021, Sihuan Pharmaceutical Holdings Group Ltd. announced that Letybo 50U, a type of botulinum toxin for Injection, exclusively distributed by the company and produced by Hugel, Inc., has been officially approved for launch in the market by the National Medical Products Administration of the People’s Republic of China.

In May 2021, Revance Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) plans to initiate its pre-approval inspection of the company’s manufacturing facility for DaxibotulinumtoxinA for Injection by the end of June 2021. In May 2020, the FDA approved Restylane Kysse by Galderma. It is for lip augmentation and the correction of upper perioral rhytids (wrinkles around upper lips) in adults over the age of 21. Some of the prominent players in the global non-invasive aesthetic treatment market are:

• Hologic, Inc.

• Allergan, Inc.

• Galderma S.A.

• Alma Lasers

• Syneron Candela

• Johnson & Johnson

• MerzPharma

• Lumenis

• Solta Medical

• Cutera Inc.

• Revance Therapeutics Inc.

Non-invasive Aesthetic Treatment Market Report Scope

Global Non-invasive Aesthetic Treatment Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global non-invasive aesthetic treatment market report on the basis of procedure, end use, and region:

• Procedure Outlook (Revenue, USD Million, 2017 - 2030)

  • Injectables

    • Botulinum Toxin

    • Calcium Hydroxylapatite

    • Hyaluronic Acid

    • Polymer Filler

    • Collagen

  • Skin Rejuvenation

    • Chemical Peel

    • Laser Skin Resurfacing

    • Photorejuvenation

  • Others

    • Hair Removal

    • Nonsurgical Fat Reduction

    • Sclerotherapy

    • Cellulite Treatment

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospital/Surgery Center

  • MedSpa

  • Traditional Spa

  • HCP owned clinic

• Regional Outlook, (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Russia

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Thailand

    • Australia

    • New Zealand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE